MedTrace Logo

Impact of Asthma Treatments on Daily Activities

NCT00350376 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2006-07-10

No results posted yet for this study

Summary

The primary objective of this web-based, cross-sectional study is to assess and compare the ability to sleep, work or go to school, and to participate in leisure activities among subjects who are receiving Xolair treatment and subjects who were eligible to receive Xolair, but instead have been using Advair for at least 1 year.

Conditions

Sponsors & Collaborators

  • Genentech, Inc.

    collaborator INDUSTRY

  • Ovation Research Group

    lead INDUSTRY

Principal Investigators

  • Susan D Mathias, MPH · Ovation Research Group

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00350376 on ClinicalTrials.gov